HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV

Published:2023-11 Issue:11 Volume:5 Page:100885
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Cargill Tamsin^ORCID,Cicconi Paola^ORCID,Brown Anthony,Holland Louise,Karanth Benaka,Rutkowski Kathryn,Ashwin Emily^ORCID,Mehta Reena,Chinnakannan Senthil,Sebastian Sarah^ORCID,Bussey Louise,Sorensen Henrik,Klenerman Paul^ORCID,Evans Thomas^ORCID,Barnes Eleanor

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference41 articles.

1. Global hepatitis report;World Health Organization,2017

2. Transforming our world: the 2030 agenda for sustainable development;United Nations,2015

3. Global health sector strategy on viral hepatitis 2016–2021;World Health Organization,2016

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

5. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection;Thimme;J Virol,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP